Cancer Registry Software Market Analysis, Size, Growth, Share, Trend, Outlook & Forecast to 2026
The global cancer registry software market size is expected to reach USD 103.5 million by 2026, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 10.5%. Growing incidence of cancer is expected to aid growth over the forecast period. Currently, cancer is the second leading cause of death globally, and according to WHO, around 70% of the deaths occur in low- and middle-income countries. Moreover, rising adoption of Electronic Health Records (EHRs) in developed countries and increasing need for cancer registries for post-marketing surveillance are among the factors further anticipated to boost the demand for cancer registry software in the coming years. Market players are constantly involved in software updation in an attempt to minimize security risks and provide efficient software, thereby increasing market visibility and adoption. For instance, in April 2018, Elekta invested in PalabraApps LLC to improve its MOSAIQ Oncology Information System software. Increasing number of clinical trials being conducted by major pharmaceutical and biotechnological companies is expected to drive the market over the forecast period. Cancer registry data helps in tracking patients for clinical trials. Moreover, the affected locations for any specific type of cancer can be identified by using this software. Major pharmaceutical companies are increasingly preferring cancer registry software owing to less requirement of internal staff, increased cost-effectiveness, and efficient management of resources, which is further widening the scope for growth.
Browse Details of Report @ https://www.grandviewresearch.com/industry-analysis/cancerregistry-software-market Cancer Registry Software Market Report Highlights
Increasing cancer burden in developing and developed countries is expected to create growth opportunities in the cancer registry software market
Standalone segment accounted for the largest revenue share in 2018, as it allows multiple system usage and provides other advantages such as automatic upgrade and easy-to-use tools
On basis of deployment model, on-premise segment held the largest share due to high data security and low risk of data breach
On the basis of component, commercial database held the largest revenue share due to better compliance features than public database
Government & third-party organizations accounted for the largest revenue owing to increasing adoption of this software by government agencies for east data tracking
North America held the largest revenue share as of 2018 due to supportive government initiatives and presence of key industry players
Asia Pacific is anticipated to witness lucrative growth due to increasing government initiatives and presence of untapped opportunities
Some of the market key players are Elekta, C/NET Solutions, Electronic Registry Systems, Inc., Onco, Inc., McKesson Corporation, and Rocky Mountain.
What questions do you have Get quick response from our industry experts @
https://www.grandviewresearch.com/request-free-consultation/6632/rfc?
Cancer Registry Software Market Segmentation Grand View Research has segmented the global cancer registry software market on the basis of software, deployment model, component, end use, and region: Cancer Registry Software, Software Outlook (Revenue, USD Million, 2014 - 2026) Standalone
Integrated
Cancer Registry Software Deployment Model Outlook (Revenue, USD Million, 2014 2026)
On-premise
Cloud-based
Cancer Registry Software Component Outlook (Revenue, USD Million, 2014 - 2026) Commercial
Public
Cancer Registry Software End-use Outlook (Revenue, USD Million, 2014 - 2026) Government & third party
Private payers
Hospital & medical practice
Pharma biotech & medical device companies
Research institutes
Cancer Registry Software Regional Outlook (Revenue, USD Million, 2014 - 2026) North America
o
U.S.
o
Canada
Europe o
U.K.
o
Germany
o
France
o
Italy
o
Spain
o
Russia
Asia Pacific o
Japan
o
China
o
India
Latin America o
Brazil
o
Mexico
Middle East & Africa o
South Africa
o
Saudi Arabia
Table of Contents
Chapter 1 Research Methodology & Scope 1.1 Market Segmentation & Scope 1.1.1 Estimates and forecast timeline 1.2 Research Methodology 1.3 Information Procurement 1.3.1 Purchased database: 1.3.2 GVR’s internal database 1.3.3 Secondary sources 1.3.4 Primary research: 1.3.5 Details of Primary Research 1.3.5.1 Data for primary interviews in North America 1.3.5.2 Data for primary interviews in Europe 1.3.5.3 Data for primary interviews in the Asia Pacific 1.3.5.4 Data for primary interviews in the Middle East and Africa 1.4 Information or Data Analysis 1.4.1 Data analysis models 1.5 Market Formulation & Validation 1.6 Model Details 1.6.1 Commodity flow analysis (Model 1) 1.6.1.1 Approach 1: Commodity flow approach 1.7 List of Secondary Sources 1.8 List of Primary Sources 1.9 Report Objectives Chapter 2 Executive Summary 2.1 Market Outlook 2.1.1 Cancer registry software market outlook, 2014 - 2026 (USD Million) 2.2 Segment Outlook 2.3 Competitive Outlook 2.4 Cancer Registry Software Market Summary, 2018
Continue……….. About Grand View Research, Inc.: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email: sales@grandviewresearch.com For More Information: http://www.grandviewresearch.com